Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands

被引:11
作者
Broers, Merel C. [1 ]
Wilde, Marcel [2 ]
Lingsma, Hester F. [3 ]
Lei, Johan [2 ]
Verhamme, Katia M. C. [2 ,4 ,5 ]
Jacobs, Bart C. [1 ,6 ]
机构
[1] Erasmus MC, Dept Neurol, Univ Med Ctr Rotterdam, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands
[2] Erasmus MC, Dept Med Informat, Univ Med Ctr Rotterdam, Rotterdam, Netherlands
[3] Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, Rotterdam, Netherlands
[4] Univ Ghent, Fac Pharmaceut Sci, Dept Bioanal, Pharmaceut Care Unit, Ghent, Belgium
[5] Onze Lieve Vrouw Hosp, Dept Infect Control & Epidemiol, Aalst, Belgium
[6] Erasmus MC, Dept Immunol, Univ Med Ctr Rotterdam, Rotterdam, Netherlands
关键词
chronic inflammatory demyelinating polyradiculoneuropathy; CIDP; epidemiology; incidence; prevalence; DIABETES-MELLITUS; POLYNEUROPATHY; CIDP; NEUROPATHIES;
D O I
10.1111/jns.12502
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare but disabling disorder that often requires long-term immunomodulatory treatment. Background incidence rates and prevalence and risk factors for developing CIDP are still poorly defined. In the current study, we used a longitudinal population-based cohort study in The Netherlands to assess these rates and demographic factors and comorbidity associated with CIDP. We determined the incidence rate and prevalence of CIDP between 2008 and 2017 and the occurrence of potential risk factors in a retrospective Dutch cohort study using the Integrated Primary Care Information (IPCI) database. Cases were defined as CIDP if the diagnosis of CIDP was described in the electronic medical file. In a source population of 928 030 persons with a contributing follow-up of 3 525 686 person-years, we identified 65 patients diagnosed with CIDP. The overall incidence rate was 0.68 per 100 000 person-years (95% CI 0.45-0.99). The overall prevalence was 7.00 per 100 000 individuals (95% CI 5.41-8.93). The overall incidence rate was higher in men compared to woman (IRR 3.00, 95% CI 1.27-7.11), and higher in elderly of 50 years or older compared with people <50 years of age (IRR 17 95% CI 4-73). Twenty percent of CIDP cases had DM and 9% a co-existing other auto-immune disease. These background rates are important to monitor changes in the frequency of CIDP following infectious disease outbreaks, identify potential risk factors, and to estimate the social and economic burden of CIDP.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
[41]   Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review [J].
Bright, Richard J. ;
Wilkinson, Jenny ;
Coventry, Brendon J. .
BMC NEUROLOGY, 2014, 14
[42]   Recurrent hypogeusia in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) [J].
Kawaguchi, Norihiko ;
Sugeno, Naoto ;
Endo, Kaoru ;
Miura, Emiko ;
Misu, Tatsuro ;
Nakashima, Ichiro ;
Itoyama, Yasuto .
JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (04) :604-605
[43]   Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy [J].
Bozovic, Ivo ;
Kacar, Aleksandra ;
Peric, Stojan ;
Nikolic, Ana ;
Bjelica, Bogdan ;
Cobeljic, Mina ;
Petrovic, Milutin ;
Stojanov, Aleksandar ;
Djuric, Vanja ;
Stojanovic, Miroslav ;
Djordjevic, Gordana ;
Martic, Vesna ;
Dominovic, Aleksandra ;
Vukojevic, Zoran ;
Basta, Ivana .
JOURNAL OF NEUROLOGY, 2017, 264 (12) :2481-2486
[44]   Juvenile Chronic Inflammatory Demyelinating Polyneuropathy Epidemiology in Sardinia, Insular Italy [J].
Sotgiu, Stefano ;
Onida, Ilaria ;
Magli, Giorgio ;
Castiglia, Paolo ;
Conti, Marta ;
Nuvoli, Angela ;
Carta, Alessandra ;
Festa, Silvia ;
Dessi, Veronica ;
Doneddu, Pietro E. ;
Nobile-Orazio, Eduardo .
NEUROPEDIATRICS, 2021, 52 (01) :56-61
[45]   The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy [J].
van Veen, R. ;
Pallada, G. ;
Wieske, L. ;
Ten Holter, S. E. M. ;
van Rootselaar, A. F. ;
Verhamme, C. ;
de Bie, R. M. A. ;
van Schaik, I. N. ;
Merkies, I. S. J. ;
Dijk, J. M. ;
Eftimov, Filip .
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 (01) :58-68
[46]   Chronic inflammatory demyelinating polyradiculoneuropathy in patients with diabetes mellitus-treatment with intravenous immunoglobulins: A systematic review [J].
Andrusiow, Szymon ;
Pawlak, Zuzanna ;
Stanczykiewicz, Bartlomiej ;
Bogunia-Kubik, Katarzyna ;
Koszewicz, Magdalena .
BIOMEDICINE & PHARMACOTHERAPY, 2023, 164
[47]   Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice [J].
Allen, Jeffrey A. ;
Eftimov, Filip ;
Querol, Luis .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (07) :805-816
[48]   Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy [J].
Kuitwaard, K. ;
Brusse, E. ;
Jacobs, B. C. ;
Vrancken, A. F. J. E. ;
Eftimov, F. ;
Notermans, N. C. ;
van Der Kooi, A. J. ;
Fokkink, W. -J. R. ;
Nieboer, D. ;
Lingsma, H. F. ;
Merkies, I. S. J. ;
van Doorn, P. A. .
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (01) :286-296
[49]   Chronic inflammatory demyelinating polyradiculoneuropathy associated intracranial hypertension [J].
Altinkaya, Ayca ;
Topcular, Baris ;
Sakalli, Nazan Karagoz ;
Kuscu, Demet Yandim ;
Kirbas, Dursun .
NEUROLOGICAL SCIENCES, 2013, 34 (06) :1027-1029
[50]   Histopathological features of chronic inflammatory demyelinating polyradiculoneuropathy. [J].
Maisonobe, T .
REVUE NEUROLOGIQUE, 2006, 162 (04) :527-532